These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Real-world experience at a Scottish university teaching hospital regarding the tolerability and persistence with topical Ciclosporin 0.1% (Ikervis) treatment in patients with dry eye disease. Hind J, Macdonald E, Lockington D. Eye (Lond); 2019 Apr; 33(4):685-686. PubMed ID: 30498263 [No Abstract] [Full Text] [Related]
8. Lichen Planus in Ocular Surface: Major Presentations and Treatments. Mohebbi M, Mirghorbani M, Banafshe Afshan A, Towfighi M. Ocul Immunol Inflamm; 2019 Apr; 27(6):987-994. PubMed ID: 29985678 [Abstract] [Full Text] [Related]
9. Evaluating the novel application of cyclosporine 0.1% in ocular surface disease. Boboridis KG, Konstas AGP. Expert Opin Pharmacother; 2018 Jun; 19(9):1027-1039. PubMed ID: 29847195 [Abstract] [Full Text] [Related]
10. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis. Pucci N, Caputo R, Mori F, De Libero C, Di Grande L, Massai C, Bernardini R, Novembre E. Int J Immunopathol Pharmacol; 2010 Jun; 23(3):865-71. PubMed ID: 20943058 [Abstract] [Full Text] [Related]
11. [Topical cyclosporine in ophthalmology: Pharmacology and clinical indications]. Levy O, Labbé A, Borderie V, Laroche L, Bouheraoua N. J Fr Ophtalmol; 2016 Mar; 39(3):292-307. PubMed ID: 26997607 [Abstract] [Full Text] [Related]
15. One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease. Baudouin C, de la Maza MS, Amrane M, Garrigue JS, Ismail D, Figueiredo FC, Leonardi A. Eur J Ophthalmol; 2017 Nov 08; 27(6):678-685. PubMed ID: 28708219 [Abstract] [Full Text] [Related]
16. Cicatrizing keratoconjunctivitis secondary to ocular lichen planus: A case report. Chamorro González-Cuevas M, Antón Modrego V, García-Valcárcel González B. Arch Soc Esp Oftalmol (Engl Ed); 2024 Aug 08; 99(8):340-343. PubMed ID: 38588999 [Abstract] [Full Text] [Related]
17. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Daniell M, Constantinou M, Vu HT, Taylor HR. Br J Ophthalmol; 2006 Apr 08; 90(4):461-4. PubMed ID: 16547328 [Abstract] [Full Text] [Related]
18. Topical cyclosporine for treatment of ocular surface disease. Foulks GN. Int Ophthalmol Clin; 2006 Apr 08; 46(4):105-22. PubMed ID: 17060797 [No Abstract] [Full Text] [Related]
19. Ciclosporin use in dry eye disease patients. Ridder WH. Expert Opin Pharmacother; 2008 Dec 08; 9(17):3121-8. PubMed ID: 19006483 [Abstract] [Full Text] [Related]
20. Brimonidine-induced unilateral ocular lichen planus: a case report. Ventura-Abreu N, Fernández-Aceñero MJ, Narváez-Palazón C, Romo-López A. Arq Bras Oftalmol; 2019 Dec 08; 82(3):236-238. PubMed ID: 30916215 [Abstract] [Full Text] [Related] Page: [Next] [New Search]